DOI: 10.1055/s-00000069

Seminars in Liver Disease

Issue 02 · Volume 26 · May 2006 DOI: 10.1055/s-002-4843 The Control of Chronic Hepatitis B: The Role for Chemoprevention Stephen A Locarnini M.B.B.S. Ph.D. F.R.C.(Path.)

FOREWORD

  • 085
    Locarnini, Stephen A.:

    The Control of Chronic Hepatitis B: The Role for Chemoprevention

  • 087
    Harrison, Tim J.:

    Hepatitis B Virus: Molecular Virology and Common Mutants

  • 097
    Bowden, Scott:

    Serological and Molecular Diagnosis

  • 104
    Visvanathan, Kumar; Lewin, Sharon R.:

    Immunopathogenesis: Role of Innate and Adaptive Immune Responses

  • 116
    Feld, Jordan J.; Heathcote, E. Jenny:

    Hepatitis B e Antigen-Positive Chronic Hepatitis B: Natural History and Treatment

  • 130
    Hadziyannis, Stephanos J.; Papatheodoridis, George V.:

    Hepatitis B e Antigen-Negative Chronic Hepatitis B: Natural History and Treatment

  • 142
    Chu, Chia-Ming; Liaw, Yun-Fan:

    Hepatitis B Virus-Related Cirrhosis: Natural History and Treatment

  • 153
    Chan, Henry Lik-Yuen; Sung, Joseph Jao-Yiu:

    Hepatocellular Carcinoma and Hepatitis B Virus

  • 162
    Bartholomeusz, Angeline; Locarnini, Stephen A.:

    Antiviral Drug Resistance: Clinical Consequences and Molecular Aspects

  • 171
    Zoulim, Fabien:

    In Vitro Models for Studying Hepatitis B Virus Drug Resistance

  • 181
    Dandri, Maura; Lutgehetmann, Marc; Volz, Tassilo; Petersen, Jörg:

    Small Animal Model Systems for Studying Hepatitis B Virus Replication and Pathogenesis

  • 192
    Hui, Chee-Kin; Lau, George K. K.:

    Current Issues and Future Directions in Treatment

  • 198
    Klion, Franklin M.:

    Book Review